Somatropin vs Thymosin Alpha-1
Overview
Somatropin is primarily a hormonal peptide, while Thymosin Alpha-1 is used for healing & recovery.
This page compares Somatropin and Thymosin Alpha-1 across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.
Side-by-side comparison
| Somatropin | Thymosin Alpha-1 | |
|---|---|---|
| Category | Hormonal | Healing & Recovery |
| Regulatory status (US) | FDA approved | Research use only |
| Typical dosage | 0.16-0.24 mg/kg/week (pediatric growth hormone deficiency); about 0.2 mg/day (adult growth hormone deficiency) | 1.6-3.2 mg |
| Frequency | daily subcutaneous injection | twice-weekly |
| Reported benefits | In labeled use, somatropin increases linear growth in children with growth failure from growth hormone deficiency, Turner syndrome, Prader-Willi syndrome, small size for gestational age and idiopathic short stature. In adults with diagnosed growth hormone deficiency, professional guidelines describe benefits in body composition, exercise capacity, skeletal integrity and quality-of-life measures, with the largest benefit in the most severely deficient patients. | Immune enhancement, antiviral properties, chronic infection support, cancer therapy adjunct |
| Reported side effects | Fluid retention, edema, arthralgia and carpal tunnel syndrome are common in adults. Labeled warnings include glucose intolerance and new-onset diabetes, intracranial hypertension, slipped capital femoral epiphysis and scoliosis progression in children, hypothyroidism, hypoadrenalism, pancreatitis and hypersensitivity reactions. | Well-tolerated. Rare: injection site reactions, mild flu-like symptoms |
Key differences
Primary use. Somatropin is categorised under Hormonal, while Thymosin Alpha-1 falls under Healing & Recovery. Their differing categories mean they are usually chosen for different goals rather than as direct substitutes.
Regulatory status. Somatropin: FDA-approved. Thymosin Alpha-1: not FDA-approved; treated as a research compound.
Dosing. Somatropin is typically dosed at 0.16-0.24 mg/kg/week (pediatric growth hormone deficiency); about 0.2 mg/day (adult growth hormone deficiency) (daily subcutaneous injection). Thymosin Alpha-1 is typically dosed at 1.6-3.2 mg (twice-weekly).
Can you stack them?
Some protocols combine peptides, but stacking Somatropin and Thymosin Alpha-1 has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.
Frequently asked questions
- What is the difference between Somatropin and Thymosin Alpha-1?
- Somatropin is primarily a hormonal peptide, while Thymosin Alpha-1 is used for healing & recovery. Somatropin is FDA-approved for one or more indications, whereas Thymosin Alpha-1 is not FDA-approved; generally classified as a research compound.
- What is Somatropin used for?
- Recombinant human growth hormone, FDA-approved for growth failure in children and growth hormone deficiency in adults.
- What is Thymosin Alpha-1 used for?
- Immune system support.
- Can you take Somatropin and Thymosin Alpha-1 together?
- Some users combine peptides within a single protocol, but stacking Somatropin and Thymosin Alpha-1 has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
- Is Somatropin or Thymosin Alpha-1 FDA-approved?
- Somatropin is FDA-approved for one or more indications. Thymosin Alpha-1 is not FDA-approved; generally classified as a research compound.
Read the full articles
- Somatropin — full monograph: mechanism, research, dosing & references
- Thymosin Alpha-1 — full monograph: mechanism, research, dosing & references